NYSE · SOLV
Healthcare · Medical - Care Facilities
$88.03
Up+$0.18 (+0.20%)
Updated Oct 6, 2026, 4:13 AM
SID Score
6.7/10
Composite research score
Smart Money
58/100
Neutral
Price performance · SOLV
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
SOLV closed at $88.03 after 20 trading sessions, down 2.31% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $87.52 | $88.395 | $86.7401 | $88.03 | 1.04M |
| Oct 2, 2026 | $88.21 | $89.025 | $87.79 | $87.85 | 880.45K |
| Oct 1, 2026 | $87.82 | $88.55 | $86.26 | $87.77 | 784.53K |
| Sep 30, 2026 | $89.40 | $89.42 | $88.13 | $88.15 | 689.74K |
| Sep 29, 2026 | $89.17 | $89.89 | $88.29 | $89.32 | 848.82K |
| Sep 28, 2026 | $89.01 | $89.885 | $88.36 | $89.54 | 649.16K |
| Sep 25, 2026 | $88.53 | $89.68 | $88.16 | $89.50 | 578.89K |
| Sep 24, 2026 | $88.54 | $89.035 | $88.12 | $88.59 | 635.84K |
| Sep 23, 2026 | $88.18 | $89.52 | $87.74 | $88.37 | 860.08K |
| Sep 22, 2026 | $89.17 | $89.405 | $88.4766 | $88.75 | 651.36K |
| Sep 21, 2026 | $88.87 | $89.615 | $88.40 | $88.84 | 660.32K |
| Sep 18, 2026 | $87.61 | $89.53 | $86.53 | $88.84 | 2.32M |
| Sep 17, 2026 | $89.09 | $89.16 | $87.30 | $87.53 | 1.04M |
| Sep 16, 2026 | $90.04 | $91.87 | $88.6766 | $88.83 | 978.09K |
| Sep 15, 2026 | $89.54 | $91.86 | $89.38 | $90.06 | 1.1M |
| Sep 14, 2026 | $88.28 | $90.3203 | $88.045 | $89.82 | 779.29K |
| Sep 11, 2026 | $88.66 | $88.84 | $86.65 | $87.45 | 774.43K |
| Sep 10, 2026 | $89.12 | $90.06 | $87.59 | $87.65 | 709.79K |
| Sep 9, 2026 | $89.22 | $90.22 | $88.8303 | $90.03 | 803.49K |
| Sep 8, 2026 | $90.74 | $91.01 | $89.295 | $90.11 | 1.11M |
The latest Smart Investors Daily articles mentioning SOLV.
Company
Market Activity
Research & News
SOLV research
Company profile and research snapshot.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 14, 2026 | BTIG | Buy | — |
| Aug 6, 2026 | Wedbush | Outperform | — |
| Aug 6, 2026 | Piper Sandler | Overweight | — |
| Aug 6, 2026 | UBS | Buy | — |
| Aug 6, 2026 | Keybanc | Overweight | — |
No generated briefing is available yet.
Yahoo · Oct 2, 2026
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
Yahoo · Sep 29, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Yahoo · Sep 25, 2026
Despite lagging behind other healthcare stocks over the past year, analysts remain fairly optimistic about Solventum, supported by the stock's bullish momentum and rosy outlook.
Yahoo · Sep 24, 2026
The global temperature management systems market is projected to grow from USD 3.56 billion in 2026 to USD 4.58 billion by 2031, at a 5.2% CAGR. Growth is driven by rising surgical volumes, cardiovascular and neurological disorders, perioperative hypothermia prevention, and targeted temperature management in critical care. Patient warming systems and perioperative care led in 2025, while Asia Pacific is expected to grow fastest. Key players include Solventum, GE HealthCare, Dräger, Ecolab, Medtr
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SOLV.
